Skip to main content
. 2017 Oct 14;9(1):66–67. doi: 10.1007/s13340-017-0338-7

Table 1.

Comparison of patient characteristics between the elderly and non-elderly patients

≥ 75 years (n = 130) 65–74 years (n = 189) < 65 years (n = 332) p
n Mean ± SD or % n Mean ± SD or % n Mean ± SD or %
Age (years) 130 80.0 ± 4.7 189 69.2 ± 2.9 332 54.5 ± 7.4 0.000*
Height (cm) 127 156.2 ± 9.6 187 161.0 ± 8.6 328 166.2 ± 8.8 0.000*
Waist circumference (cm) 80 85.7 ± 10.5 120 87.3 ± 9.6 193 89.9 ± 12.0 0.009*
Duration of diabetes (days) 111 121.4 ± 94.6 181 114.1 ± 78.4 308 95.4 ± 74.4 0.003*
Sex (male) 67 51.5 117 61.9 250 75.3 0.000*
Smoking 13 10.3 34 18.6 96 29.8 0.000*
Alcohol consumption 39 31.7 82 45.1 180 56.1 0.000*
Retinopathy 8 6.2 8 4.2 32 9.6 0.064
Arteriosclerosis obliterans 6 4.6 21 11.1 28 8.4 0.122
Stroke 0 0.0 1 0.6 0 0.0 0.288
Myocardial infarction 7 5.4 5 2.6 6 1.8 0.108
Angina pectoris 8 6.2 8 4.2 11 3.3 0.387
Cardiac failure 5 3.8 2 1.1 4 1.2 0.102
Atrial fibrillation 4 3.1 5 2.6 7 2.1 0.817
Diet/exercise therapy 49 37.7 48 25.4 92 27.7 0.044*
Low dose of glimepiride 18 13.8 25 13.2 29 8.7 0.153
Medium dose of glimepiride 9 6.9 21 11.1 20 6.0 0.104
BG 9 6.9 25 13.2 65 19.6 0.002*
TZD 7 5.4 12 6.3 19 5.7 0.929
α-GI 5 3.8 3 1.6 10 3.0 0.446
Multidrug therapy 33 25.4 55 29.1 97 29.2 0.692
Antihypertensive drug 81 62.3 106 56.1 144 43.4 0.000*
Antihyperlipidemic drug 62 47.7 94 49.7 156 47.0 0.832
Antihyperuricemic drug 6 4.6 9 4.8 16 4.8 0.996
Antithrombogenic drug 22 16.9 44 23.3 52 15.7 0.088

p < 0.05